AchieveCE The Opioid Epidemic: Searching for Solutions Webcast
According to the 2015 National Survey on Drug Use and Health, approximately 3.8 million people (1.4% of those ages 12 or older) reported misusing prescription pain relievers, while another 329,000 people reported using heroin. Within the same year, 52,404 lethal overdoses took place, making drug overdose the leading cause of accidental death within the United States. Stancliff et al estimated that as of 2012, approximately 80% of people dependent on heroin or prescription opioids were not engaged in any treatment and many in treatment do not use the most effective medication-assisted treatments available to them.
Despite recent increased awareness of opioid use disorder (OUD) and efforts to improve access to care, several barriers to treatment still exist, including financial, geographic, regulatory, and social. In 2012, only 2.2% of physicians in the United States obtained waivers to prescribe buprenorphine for the treatment of OUD. Of those who received waivers, 41.6% were psychiatrists. This may be perceived as a potential barrier to OUD treatment as patients are often resistant to referrals to psychiatric and/or addiction clinics given the stigmas commonly surrounding addiction and mental health. Furthermore, physicians with waivers were found to practice primarily in urban settings, leaving a large portion of the rural population without access to buprenorphine treatment.
With all this in mind, education is needed in regards to current and emerging treatment options for OUD available to multiple patient populations. Also, with the deaths due to drug overdoses still elevated, education on how to recognize and reverse an opioid overdose is needed.
This presentation will address the above needs by discussing the science behind opioid use disorder as well as reflect upon current statistics associated with its impact on the United States. During the discussion, opioid overdose risks will be discussed and participants will be able to practice recognizing key symptoms of an overdose situation. Steps of using naloxone will be discussed and connected to how to appropriately seek out treatment for maintenance of opioid use disorder. Finally, new buprenorphine products and the potential role of naltrexone will be applied to this stigmatized population.
Cost: $15.00Add to cart
Key Features
- Video-based Learning
- Downloadable Handout
- Desktop, Mobile, and Tablet friendly.
- Self-Paced Learning
- No Time Limits or Expiration
- Includes an evaluation and assessment
- Downloadable Certificate
- Credits are reported to CE Broker and/or CPE automatically within 24 hours
Topics Covered
Background on Opioid Overdose
National Drug-Involved Overdose Deaths
The Opioid Epidemic in America
Opioid Prescribing Rates
Heroin Use and Deaths
What are Opioids?
What is an Opioid Overdoes?
Risk Factors
Side Effects
Detoxification/ Maintenance
Treatment Guidelines
Methadone vs Buprenorphine
Special Populations: Pregnancy and Adolescents
Updates in Treatment
Learning Objectives
At the conclusion of this continuing education activity, the participant will be able to:
1. Discuss the pertinent nature of opioid use/abuse throughout the United States
2. Describe how to recognize and treat an opioid/heroin overdose
3. Describe risks associated with an opioid/heroin overdose
4. List current and upcoming treatment options for opioid use disorder
Target Audience
Dental Professional, Nurse, Pharmacist, Pharmacy Technician, Physician, Physician Assistant
Additional credit info
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Continuing Education Company, Inc. and AchieveCE. Continuing Education Company, Inc. is accredited by the ACCME to provide continuing medical education for physicians. Continuing Education Company, Inc. designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. AchieveCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. AchieveCE is also accredited by the Florida Board of Pharmacy (provider no. 50-20641). This course is approved by CE Broker, with CE Broker No. 20-869919. Universal Activity Number: Pharmacist: 0657-0000-21-071-H01-P Pharmacy Technician: 0657-0000-21-071-H01-T AchieveCE is an approved provider of nursing continuing professional development by the Georgia Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. GNA Approved Provider Number is 4003268. Start Date: 07/14/2022 Expiration Date: 01/14/2023 AchieveCE’s dental CE courses are accredited through the Academy of General Dentistry (AGD) with provider ID #386503.